209
Views
51
CrossRef citations to date
0
Altmetric
Review

Peptidomimetics as a new generation of antimicrobial agents: current progress

Pages 229-237 | Published online: 30 Aug 2014

References

  • LivermoreDMCurrent epidemiology and growing resistance of gram-negative pathogensKorean J Intern Med201227212814222707882
  • ScottRWDeGradoWFTewGNDe novo designed synthetic mimics of antimicrobial peptidesCurr Opin Biotechnol200819662062718996193
  • TewGNScottRWKleinMLDegradoWFDe novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applicationsAcc Chem Res2010431303919813703
  • WuMMaierEBenzRHancockREMechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coliBiochemistry199938227235724210353835
  • FriedrichCLMoylesDBeveridgeTJHancockREAntibacterial action of structurally diverse cationic peptides on gram-positive bacteriaAntimicrob Agents Chemother20004482086209210898680
  • ZhangLDhillonPYanHFarmerSHancockREInteractions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosaAntimicrob Agents Chemother200044123317332111083634
  • HancockRESahlHGAntimicrobial and host-defense peptides as new anti-infective therapeutic strategiesNat Biotechnol200624121551155717160061
  • Méndez-SamperioPRole of antimicrobial peptides in host defense against mycobacterial infectionsPeptides200829101836184118582513
  • HancockRELehrerRCationic peptides: a new source of antibioticsTrends Biotechnol199816282889487736
  • MarrAKGooderhamWJHancockREAntibacterial peptides for therapeutic use: obstacles and realistic outlookCurr Opin Pharmacol20066546847216890021
  • BrogdenKAAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nat Rev Microbiol20053323825015703760
  • ShaiYMechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptidesBiochim Biophys Acta199914621–2557010590302
  • ShaiYMode of action of membrane active antimicrobial peptidesBiopolymers200266423624812491537
  • HuangYHuangJChenYAlpha-helical cationic antimicrobial peptides: relationships of structure and functionProtein Cell20101214315221203984
  • LehrerRILuWα-Defensins in human innate immunityImmunol Rev201224518411222168415
  • PetersBMShirtliffMEJabra-RizkMAAntimicrobial peptides: primeval molecules or future drugs?PLoS Pathog2010610e100106721060861
  • KarlssonAJPomerantzWCWeisblumBGellmanSHPalecekSPAntifungal activity from 14-helical beta-peptidesJ Am Chem Soc200612839126301263117002340
  • KarlssonAJPomerantzWCNeilsenKJGellmanSHPalecekSPEffect of sequence and structural properties on 14-helical beta-peptide activity against Candida albicans planktonic cells and biofilmsACS Chem Biol20094756757919518070
  • KarlssonAJFlessnerRMGellmanSHLynnDMPalecekSPPolyelectrolyte multilayers fabricated from antifungal β-peptides: design of surfaces that exhibit antifungal activity against Candida albicansBiomacromolecules20101192321232820831274
  • ChongsiriwatanaNPPatchJACzyzewskiAMPeptoids that mimic the structure, function, and mechanism of helical antimicrobial peptidesProc Natl Acad Sci U S A200810582794279918287037
  • OlsenCAZieglerHLNielsenHMFrimodt-MøllerNJaroszewskiJWFranzykHAntimicrobial, hemolytic, and cytotoxic activities of beta-peptoid-peptide hybrid oligomers: improved properties compared to natural AMPsChembiochem201011101356136020503219
  • KapoorRWadmanMWDohmMTCzyzewskiAMSpormannAMBarronAEAntimicrobial peptoids are effective against Pseudomonas aeruginosa biofilmsAntimicrob Agents Chemother20115563054305721422218
  • ChongsiriwatanaNPMillerTMWetzlerMShort alkylated peptoid mimics of antimicrobial lipopeptidesAntimicrob Agents Chemother201155141742020956607
  • KapoorREimermanPRHardyJWCirilloJDContagCHBarronAEEfficacy of antimicrobial peptoids against Mycobacterium tuberculosisAntimicrob Agents Chemother20115563058306221464254
  • HuangMLShinSBBensonMATorresVJKirshenbaumKA comparison of linear and cyclic peptoid oligomers as potent antimicrobial agentsChemMedChem20127111412221990117
  • HuaJYamarthyRFelsensteinSScottRWMarkowitzKDiamondGActivity of antimicrobial peptide mimetics in the oral cavity: I. Activity against biofilms of Candida albicansMol Oral Microbiol201025641842521040515
  • HuaJScottRWDiamondGActivity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activityMol Oral Microbiol201025642643221040516
  • ObrechtDRobinsonJABernardiniFRecent progress in the discovery of macrocyclic compounds as potential anti-infective therapeuticsCurr Med Chem2009161426519149562
  • SrinivasNJetterPUeberbacherBJPeptidomimetic antibiotics target outer-membrane biogenesis in Pseudomonas aeruginosaScience201032759681010101320167788
  • HuYLiXSebtiSMChenJCaiJDesign and synthesis of AApeptides: a new class of peptide mimicsBioorg Med Chem Lett20112151469147121292484
  • NiuYWuHLiYAApeptides as a new class of antimicrobial agentsOrg Biomol Chem201311264283429023722277
  • NiuYHuYWuHCaiJSynthesis of AApeptidesMethods Mol Biol20131081354624014432
  • IshitsukaYArntLMajewskiJAmphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertionJ Am Chem Soc200612840131231312917017792
  • ClaudonPVioletteALamourKConsequences of isostructural main-chain modifications for the design of antimicrobial foldamers: helical mimics of host-defense peptides based on a heterogeneous amide/urea backboneAngew Chem Int Ed Engl201049233333619957258
  • Dragulescu-AndrasiARapireddySFrezzaBMGayathriCGilRRLyDHA simple gamma-backbone modification preorganizes peptide nucleic acid into a helical structureJ Am Chem Soc200612831102581026716881656
  • TedeschiTSforzaSDossenaACorradiniRMarchelliRLysine-based peptide nucleic acids (PNAs) with strong chiral constraint: control of helix handedness and DNA binding by chiralityChirality200517SupplS196S20415952136
  • TedeschiTChiariMGalavernaGDetection of the R553X DNA single point mutation related to cystic fibrosis by a “chiral box” D-lysine-peptide nucleic acid probe by capillary electrophoresisElectrophoresis200526224310431616287174
  • InokuchiEYamadaAHozumiKDesign and synthesis of amidine-type peptide bond isosteres: application of nitrile oxide derivatives as active ester equivalents in peptide and peptidomimetics synthesisOrg Biomol Chem2011993421342721423919
  • PadheeSHuYNiuYNon-hemolytic α-AApeptides as antimicrobial peptidomimeticsChem Commun (Camb)201147349729973121779608
  • NiuYPadheeSWuHIdentification of γ-AApeptides with potent and broad-spectrum antimicrobial activityChem Commun (Camb)20114744121971219921963627
  • WalshPSKusakaRBuchananEGCyclic constraints on conformational flexibility in γ-peptides: conformation specific IR and UV spectroscopyJ Phys Chem A201311747123501236224147873
  • JamesWHBuchananEGMüllerCWEvolution of amide stacking in larger γ-peptides: triamide H-bonded cyclesJ Phys Chem A201111547137831379821978283
  • WuHAminMNNiuYSolid-phase synthesis of γ-AApeptides using a submonomeric approachOrg Lett201214133446344922731678
  • NiuYJonesAJWuHVaraniGCaiJγ-AApeptides bind to RNA by mimicking RNA-binding proteinsOrg Biomol Chem20119196604660921826330
  • YangYNiuYHongHRadiolabeled γ-AApeptides: a new class of tracers for positron emission tomographyChem Commun (Camb)201248637850785222785080
  • NiuYBaiGWuHCellular translocation of a γ-AApeptide mimetic of Tat peptideMol Pharm2012951529153422413929
  • BaiGPadheeSNiuYCellular uptake of an α-AApeptideOrg Biomol Chem20121061149115322193209
  • SchmittMAWeisblumBGellmanSHInterplay among folding, sequence, and lipophilicity in the antibacterial and hemolytic activities of alpha/beta-peptidesJ Am Chem Soc2007129241742817212422
  • MoweryBPLeeSEKissounkoDAMimicry of antimicrobial host-defense peptides by random copolymersJ Am Chem Soc200712950154741547618034491
  • NiuYPadheeSWuHLipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agentsJ Med Chem20125584003400922475244
  • IvankinALivneLMorARole of the conformational rigidity in the design of biomimetic antimicrobial compoundsAngew Chem Int Ed Engl201049458462846520872385
  • KurodaKCaputoGAAntimicrobial polymers as synthetic mimics of host-defense peptidesWiley Interdiscip Rev Nanomed Nanobiotechnol201351496623076870
  • TakahashiHPalermoEFYasuharaKCaputoGAKurodaKMolecular design, structures, and activity of antimicrobial peptide-mimetic polymersMacromol Biosci201313101285129923832766
  • RekdalØHaugBEKalaajiMRelative spatial positions of tryptophan and cationic residues in helical membrane-active peptides determine their cytotoxicityJ Biol Chem2012287123324422057278
  • McGrathDMBarbuEMDriessenWHMechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimeticProc Natl Acad Sci U S A201311093477348223345420
  • BarbuEMShiraziFMcGrathDMAn antimicrobial peptidomimetic induces Mucorales cell death through mitochondria-mediated apoptosisPLoS One2013810e7698124098573
  • HaugBEStensenWKalaajiMRekdalØSvendsenJSSynthetic antimicrobial peptidomimetics with therapeutic potentialJ Med Chem200851144306431418570363
  • LuFChiSWKimDHHanKHKuntzIDGuyRKProteomimetic libraries: design, synthesis, and evaluation of p53-MDM2 interaction inhibitorsJ Comb Chem20068331532516677000
  • NiuYWangREWuHCaiJRecent development of small antimicrobial peptidomimeticsFuture Med Chem20124141853186223043481
  • ChoiSIsaacsAClementsDDe novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamersProc Natl Acad Sci U S A2009106176968697319359494
  • Polymedix IncBrilacidin (PMX-30063) Antibiotic Fact SheetRandor, PAPolyMedix, Inc2013 Available from: http://files.shareholder.com/downloads/ABEA-4ITCYZ/1997024712x0x611205/FEA66C67-D02F-4FF2-B230-AA711F46ED7F/PMX-30063_Antibiotic_Fact_Sheet_Nov_2012_.pdfAccessed February 10, 2013
  • BlancoJJacototECabreraCThe implication of the chemokine receptor CXCR4 in HIV-1 envelope protein-induced apoptosis is independent of the G protein-mediated signallingAIDS199913890991710371171
  • TanakaGNakaseIFukudaYCXCR4 stimulates macropinocytosis: implications for cellular uptake of arginine-rich cell-penetrating peptides and HIVChem Biol201219111437144623177198
  • TamamuraHFujiiNThe therapeutic potential of CXCR4 antagonists in the treatment of HIV infection, cancer metastasis and rheumatoid arthritisExpert Opin Ther Targets2005961267128216300475
  • TsutsumiHTanakaTOhashiNTherapeutic potential of the chemokine receptor CXCR4 antagonists as multifunctional agentsBiopolymers200788227928917167792
  • TamamuraHTsutsumiHMasunoHFujiiNDevelopment of low molecular weight CXCR4 antagonists by exploratory structural tuning of cyclic tetra- and pentapeptide-scaffolds towards the treatment of HIV infection, cancer metastasis and rheumatoid arthritisCurr Med Chem20071419310217266570
  • MoncunillGArmand-UgónMClotet-CodinaIAnti-HIV activity and resistance profile of the CXC chemokine receptor 4 antagonist POL3026Mol Pharmacol20087341264127318182480
  • ChoiWTTianSDongCZUnique ligand binding sites on CXCR4 probed by a chemical biology approach: implications for the design of selective human immunodeficiency virus type 1 inhibitorsJ Virol20057924153981540416306611
  • LaLondeJMKwonYDJonesDMStructure-based design, synthesis, and characterization of dual hotspot small-molecule HIV-1 entry inhibitorsJ Med Chem20125594382439622497421
  • MbembaEBenjouadASaffarLGattegnoLGlycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cellsVirology1999265235436410600606
  • TanakaTNomuraWNarumiTStructure-activity relationship study on artificial CXCR4 ligands possessing the cyclic pentapeptide scaffold: the exploration of amino acid residues of pentapeptides by substitutions of several aromatic amino acidsOrg Biomol Chem20097183805380919707686
  • DemmerODijkgraafISchumacherUDesign, synthesis, and functionalization of dimeric peptides targeting chemokine receptor CXCR4J Med Chem201154217648766221905730
  • GravelSMaloufCBoulaisPEThe peptidomimetic CXCR4 antagonist TC14012 recruits beta-arrestin to CXCR7: roles of receptor domainsJ Biol Chem201028549379393794320956518
  • VeldkampCTZiarekJJPetersonFCChenYVolkmanBFTargeting SDF-1/CXCL12 with a ligand that prevents activation of CXCR4 through structure-based drug designJ Am Chem Soc2010132217242724320459090
  • O’BrienWASumner-SmithMMaoSHSadeghiSZhaoJQChenISAnti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactionsJ Virol1996705282528318627756
  • DoranzBJGrovit-FerbasKSharronMPA small-molecule inhibitor directed against the chemokine receptor CXCR4 prevents its use as an HIV-1 coreceptorJ Exp Med19971868139514009334380
  • ZhouNZhangXFanXThe N-terminal domain of APJ, a CNS-based coreceptor for HIV-1, is essential for its receptor function and coreceptor activityVirology20033171849414675627
  • ZhangJMulvenonAMakarovEAntiviral peptide nanocomplexes as a potential therapeutic modality for HIV/HCV co-infectionBiomaterials201334153846385723403120
  • SzakácsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov20065321923416518375
  • HoskinDWRamamoorthyAStudies on anticancer activities of antimicrobial peptidesBiochim Biophys Acta20081778235737518078805
  • KimJMLeeYHKuCRLeeEJThe cyclic pentapeptide d-Arg3FC131, a CXCR4 antagonist, induces apoptosis of somatotrope tumor and inhibits tumor growth in nude miceEndocrinology2011152253654421147876
  • ShinDYKimKJKuCRDifferent CXCR4 expression according to various histologic subtype of papillary thyroid carcinomaEndocr Pathol201324416917623963832
  • JenssenHHamillPHancockREPeptide antimicrobial agentsClin Microbiol Rev200619349151116847082
  • PapoNShaiYHost defense peptides as new weapons in cancer treatmentCell Mol Life Sci2005627–878479015868403
  • SchweizerFCationic amphiphilic peptides with cancer-selective toxicityEur J Pharmacol20096251–319019419835863
  • SiddiqueeKAGunningPTGlennMAn oxazole-based small-molecule Stat3 inhibitor modulates Stat3 stability and processing and induces antitumor cell effectsACS Chem Biol200721278779818154266
  • McDanielJRCallahanDJChilkotiADrug delivery to solid tumors by elastin-like polypeptidesAdv Drug Deliv Rev201062151456146720546809
  • OnwulataCIEncapsulation of new active ingredientsAnnu Rev Food Sci Technol2012318320222149076
  • WangXZhangXSeparation, antitumor activities, and encapsulation of polypeptide from Chlorella pyrenoidosaBiotechnol Prog201329368168723606619
  • HouLZhaoXWangPNingQMengMLiuCAntitumor activity of antimicrobial peptides containing CisoDGRC in CD13 negative breast cancer cellsPLoS One201381e5349123326440
  • GuYLiuSLJuWZLiCYCaoPAnalgesic-antitumor peptide induces apoptosis and inhibits the proliferation of SW480 human colon cancer cellsOncol Lett20135248348823420047